Hennepin Minnesota Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• County: Hennepin
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Hennepin Minnesota Collateral License Agreement is a legal document that defines the terms and conditions of a collaboration between Gentling, Inc. and The University of North Texas Health Science Center. This agreement grants Gentling, Inc. limited rights and access to certain intellectual property developed or owned by the Health Science Center. Keywords: Hennepin Minnesota, Collateral License Agreement, Gentling, Inc., University of North Texas Health Science Center, collaboration, intellectual property, rights, access. The specifics of the Hennepin Minnesota Collateral License Agreement may vary depending on the scope and nature of the collaboration. However, some potential types or provisions that could exist within the agreement include: 1. Technology Transfer Agreement: This type of collateral license agreement focuses on the transfer of technology developed by the University of North Texas Health Science Center to Gentling, Inc. It outlines the specifics of how the intellectual property will be shared, commercialized, and protected. 2. Research and Development Agreement: This agreement type focuses on joint research and development efforts between Gentling, Inc. and the Health Science Center. It outlines the terms and conditions related to the joint efforts, including data ownership, publication rights, and intellectual property rights. 3. Commercialization Agreement: In cases where the collaboration aims to commercialize a specific technology or product, a collateral license agreement may focus on the rights and obligations related to the commercialization process. It could include provisions related to marketing, distribution, and licensing. 4. Royalty Sharing Agreement: If the collaboration involves the utilization of existing intellectual property rights owned by the Health Science Center, a collateral license agreement can include provisions on royalties or financial compensation to be paid to the Center by Gentling, Inc. This ensures that the Center receives appropriate recognition and compensation for the use of its intellectual property. These are just some possible variations and types of collateral license agreements that could exist between Gentling, Inc. and The University of North Texas Health Science Center. The specific agreement terms and provisions will depend on the goals, objectives, and nature of the collaboration between the two parties.

The Hennepin Minnesota Collateral License Agreement is a legal document that defines the terms and conditions of a collaboration between Gentling, Inc. and The University of North Texas Health Science Center. This agreement grants Gentling, Inc. limited rights and access to certain intellectual property developed or owned by the Health Science Center. Keywords: Hennepin Minnesota, Collateral License Agreement, Gentling, Inc., University of North Texas Health Science Center, collaboration, intellectual property, rights, access. The specifics of the Hennepin Minnesota Collateral License Agreement may vary depending on the scope and nature of the collaboration. However, some potential types or provisions that could exist within the agreement include: 1. Technology Transfer Agreement: This type of collateral license agreement focuses on the transfer of technology developed by the University of North Texas Health Science Center to Gentling, Inc. It outlines the specifics of how the intellectual property will be shared, commercialized, and protected. 2. Research and Development Agreement: This agreement type focuses on joint research and development efforts between Gentling, Inc. and the Health Science Center. It outlines the terms and conditions related to the joint efforts, including data ownership, publication rights, and intellectual property rights. 3. Commercialization Agreement: In cases where the collaboration aims to commercialize a specific technology or product, a collateral license agreement may focus on the rights and obligations related to the commercialization process. It could include provisions related to marketing, distribution, and licensing. 4. Royalty Sharing Agreement: If the collaboration involves the utilization of existing intellectual property rights owned by the Health Science Center, a collateral license agreement can include provisions on royalties or financial compensation to be paid to the Center by Gentling, Inc. This ensures that the Center receives appropriate recognition and compensation for the use of its intellectual property. These are just some possible variations and types of collateral license agreements that could exist between Gentling, Inc. and The University of North Texas Health Science Center. The specific agreement terms and provisions will depend on the goals, objectives, and nature of the collaboration between the two parties.